Good morning. What happens to an organization after it achieves a moonshot? That has been Albert Bourla’s reality, post-COVID. As the CEO of Pfizer, a company he first joined in 1993, Bourla—a ...

During an appearance on CBS News Sunday, Pfizer CEO Albert Bourla said that Americans would need a fourth dose of a COVID-19 vaccine to fend off future variants of the virus. Speaking with anchor ...

SAN FRANCISCO, Jan 12 (Reuters) - Pfizer is preparing for ‌a consumer market for obesity drugs on ‌par with the booming business it saw after it launched erectile dysfunction drug Viagra in 1998, CEO ...

・Pfizer scrapped its own obesity drug candidate, Danuglipron, in early 2025, citing risks of liver enzyme elevations. ・The company purchased Metsera in November for up to $10 billion to reignite its ...

We recently published 10 Stocks Jim Cramer Talked About. Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer talked about. Pharma giant Pfizer Inc. (NYSE:PFE)’s shares are down by 4.7% over the ...

Pfizer Inc. (NYSE: PFE) CEO Albert Bourla sharply criticized Robert F. Kennedy's views on vaccines, calling them "anti-science." He suggested that meaningful progress on immunization policy would ...

Several of pharma’s top leaders scored large pay bumps last year, including two new chiefs who joined the “$30 million club.” ...

NEW YORK - The CEO of pharmaceutical giant Pfizer said during a televised interview Thursday that people will "likely" need a third dose of the COVID-19 vaccine. CEO Albert Bourla told CNBC that the ...

AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) both reported fourth quarter earnings in early February. AbbVie posted record net ...